Halozyme and Incyte sign drug delivery licensing agreement
Go back to Halozyme and Incyte sign drug delivery licensing agreement| Halozyme Therapeutics, Inc. (NASDAQ: HALO) | Delayed: 108.17 +2.05 (1.93%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $106.12 | 52 Week High | $18.39 | |||
| Open | $106.20 | 52 Week Low | $6.96 | |||
| Day High | $108.49 | P/E | N/A | |||
| Day Low | $105.91 | EPS | $-0.58 | |||
| Volume | 1,173,974 | |||||
| Incyte Genomics, Inc. (NASDAQ: INCY) | Delayed: 127.81 +0.59 (0.46%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $127.22 | 52 Week High | $118.49 | |||
| Open | $126.45 | 52 Week Low | $55.00 | |||
| Day High | $129.92 | P/E | N/A | |||
| Day Low | $125.60 | EPS | $-0.56 | |||
| Volume | 1,367,412 | |||||
